Polyclonal Rabbit ACOT4 Antibody
- Known as:
- Polyclonal Rabbit ACOT4 Antibody
- Catalog number:
- KA0072
- Product Quantity:
- 100ul
- Category:
- -
- Supplier:
- KareBay
- Gene target:
- Polyclonal Rabbit ACOT4 Antibody
Ask about this productRelated genes to: Polyclonal Rabbit ACOT4 Antibody
- Gene:
- ACOT4 NIH gene
- Name:
- acyl-CoA thioesterase 4
- Previous symbol:
- -
- Synonyms:
- FLJ31235, PTE-Ib, PTE2B
- Chromosome:
- 14q24.3
- Locus Type:
- gene with protein product
- Date approved:
- 2005-09-08
- Date modifiied:
- 2016-10-05
Related products to: Polyclonal Rabbit ACOT4 Antibody
Related articles to: Polyclonal Rabbit ACOT4 Antibody
- Cholesterol imbalances and elevated blood pressure (BP) are closely interrelated risk factors for cardiovascular disease (CVD) and are subject to genetic influences. We sought to identify novel associations between candidate genetic coding variants and CVD traits in our isolated study cohort and validate them in a general population cohort. - Source: PubMed
Publication date: 2026/02/09
Meyjes-Brown Jacob W ISutherland Heidi GTran Kim NganBenton Miles CLea Rod AGriffiths Lyn R - Psoralea corylifolia(PF) is widely utilized for the treatment of conditions such as kidney yang deficiency, frequent urination, and cold pain in the waist and knees. However, both basic research and clinical reports indicate that it induce hepatotoxicity. Our preliminary research has confirmed that PF has hepatotoxicity and in vitro research indicated that psoralidin is hepatotoxic. but it remains unclear whether psoralidin is the hepatotoxic component of PF and the mechanism of psoralidin induces hepatotoxicity. This study aimed to investigate the hepatotoxicity induced by psoralidin and its toxic mechanisms. - Source: PubMed
Publication date: 2026/02/02
Guo ZhaojuanPeng XiyiQin DashengZhang LinTu CanWang Ting - Oncogenesis and tumor progression have been linked to abnormal metabolism. We aimed to investigate the potential connection between sulfur metabolism-related genes and clinical features of patients with breast cancer. - Source: PubMed
Publication date: 2026/01/16
Yuan YuanZhang ShuyaoFu JialeiZhou Fei - Cervical cancer, in which cervical squamous cell carcinoma (CSCC) accounts for 60-70% of cases, has a poor prognosis and poses a significant health threat to global patients. Lipid metabolism reprogramming is a key driver of tumor progression and tumor microenvironment (TME) regulation, making it a promising target for improving the efficacy of immunotherapy. This study aimed to construct a lipid metabolism prognostic signature (LMPS) in CSCC and identify key genes involved in tumor progression. - Source: PubMed
Publication date: 2025/10/14
Bai GaigaiChen FanghuaQiu JunjunHua Keqin - Obesity-associated adipose inflammation and gut dysbiosis exacerbate metabolic dysfunction, yet effective therapies are scarce. This study introduces a novel acidic polysaccharide (FOFTP2) isolated from postfermented dark tea by , focusing on its dual immunomodulatory and prebiotic effects. Structural characterization revealed that FOFTP2 primarily consists of →4)-α-D-GalA-6-O-Me-(1→ residues, along with rhamnogalacturonan-I/II and arabinogalactan-I/II side chains. Functional analysis demonstrated that FOFTP2 effectively repolarizes pro-inflammatory M1 adipose tissue macrophages to anti-inflammatory M2 phenotypes, reduces adipocyte hypertrophy, and improves systemic dyslipidemia. Additionally, FOFTP2 enriches beneficial gut taxa (, ) while suppressing inflammation-associated genera (, ). Multiomics analyses show that FOFTP2 mitigates adipose inflammation and gut dysbiosis, linked to the upregulation of lipid catabolism genes (, , ) and modulation of immune signaling pathways (, , ). These findings suggest that FOFTP2 acts as a dual-targeting prebiotic immunomodulator, offering a fermented tea-derived strategy to disrupt the gut-adipose inflammatory axis in metabolic disease. - Source: PubMed
Publication date: 2025/09/19
Li MinniWu HanLi YidiWang XinyiXu NaGe HuifangGao XuelingJiang XiaoyiJiang ZhengnanXie ZhongwenWang YiJunLi DaxiangWang Hongyan